25.08.2017
- Mylan has finalized a $465 million settlement with the US Department of Justice (DoJ) resolving claims relating to its EpiPen emergency allergy treatment. The DoJ’s announcement of...
25.08.2017
- The Janssen unit of Johnson & Johnson has hit out at plans by the US state of Florida to execute a death row prisoner using an experimental lethal injection that contains an active...
07.02.2017
- US drugmaker Mylan is facing a probe from the Federal Trade Commission (FTC) as to whether it has violated antitrust laws in protecting its EpiPen from lower-priced competitors...
17.11.2016
- US Senator Chuck Grassley, chairman of the Judiciary Committee, is urging the Department of Justice (DoJ) to reconsider its decision to refuse to appear voluntarily at a Judiciary...
12.10.2016
- Mylan Pharmaceuticals, generics specialist headquartered in both the US and the UK, has paid $465m to the US government to settle claims that it improperly classified its EpiPen...
19.09.2016
- Heather Bresch, head of Mylan Pharmacueticals, will face questions from the US Congress s at a hearing this week focused on sharp price increases for the company's life-saving...
15.02.2016
- On the rebound from its failed $27 billion hostile bid for Perrigo, Netherlands-domiciled, US-managed drugmaker Mylan has announced it will acquire Sweden’s Meda for 83.6 billion...
16.11.2015
- Mylan’s seven month-long, $26 billion long-shot hostile bid for Perrigo has ended in defeat for the Netherlands-based drugmaker. By the target deadline of Friday, Nov. 13, only 40%...
